Clinical Trials Logo

Poor Sleep Quality clinical trials

View clinical trials related to Poor Sleep Quality.

Filter by:
  • None
  • Page 1

NCT ID: NCT06430086 Not yet recruiting - Poor Sleep Quality Clinical Trials

Mechanistic Effect of Walnut Consumption on Sleep Quality

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Poor sleep quality is very common in modern society. Walnuts contain many nutrients that may be helpful for sleep, including melatonin and polyphenols. Some studies show that eating foods high in melatonin and polyphenols improves sleep quality, but walnuts have not been studied specifically. This study proposes to test if eating walnuts improves sleep compared to a food that lacks these sleep-promoting factors. The investigators expect that walnut consumption for 4 days will increase melatonin levels and lead to better sleep quality compared to a high-carbohydrate, high-sugar food. The study will enroll middle-aged and older adults with sleep complaints to participate in this study. Each person will eat the two different foods for 4 days each in random order. The 4-day periods will be separated by at least 2-3 weeks. Sleep quality will be measured by questionnaire and with a wrist monitor every day. The investigators will also do a sleep study using electroencephalography (EEG) on night 3 and take measures of circadian physiology (natural body rhythms) in the laboratory on day 4 (including overnight) by measuring body temperature and blood and urine melatonin. The study findings may provide new options to improve sleep health from increased walnut consumption.

NCT ID: NCT05237037 Recruiting - Poor Sleep Quality Clinical Trials

Assessment of Sleep Quality in Cannabinoid Therapy

Start date: August 22, 2022
Phase:
Study type: Observational

The current study aims to assess the impact of starting cannabinoid therapy on sleep quality for individuals with sleep disturbance.

NCT ID: NCT04930848 Completed - Poor Sleep Quality Clinical Trials

Effectiveness of Aqueous Extract(Tea) of Euphorbia Hirta (Dudhiya) in Improving Sleep Quality

Start date: April 3, 2021
Phase: N/A
Study type: Interventional

Sound sleep is needed for our overall health and optimum our productivity. Sleep quality affects people's work performance, mood, safety, and quality of life. Changing times and advancements in technology couples with altered lifestyles have taken a toll on human health. Poor sleep quality reduces short-term memory, cognitive abilities, and motor skills for all age groups. The high prevalence of poor sleep quality in every age group has triggered a growing worldwide demand for a safe, effective and easily available herbal cure. Studies shown that, E. hirta has sedative action. For this, I hypothesized that oral intake of aqueous extract (tea) of E.hirta is efficacious in improving sleep quality. In this study I assessed the efficacy of aqueous extract (tea) of Euphorbia hirta (Dudhiya) in improving sleep quality in persons aged 20 to 50 years with self-reported sleep disturbance. The main objective of the study is to assess the efficacy of oral intake of aqueous extract of E.hirta in improving sleep quality in terms of having regular sound sleep and freshness in the daytime work. A total of 32 adults with poor sleep quality was recruited for this study and included both of male and female. Duration of the study was 05 months and active participation of each participant was 2 consecutive weeks or 14 days. Study area was included Dhaka, Narayanganj and Munshiganj districts and study center was Dr. Hakeem Md. Yousuf Harun Bhuiyan Hospital, Hamdard University Bangladesh.

NCT ID: NCT01980719 Completed - Pain Clinical Trials

Molecular Determinants of Persistent Cancer Related Fatigue

MDOF
Start date: July 2010
Phase: N/A
Study type: Observational

The purpose of this study is to determine if inflammatory markers in blood as well as brain neurotransmitters (markers of in-brain activity and metabolism) are related to long-term or chronic fatigue.

NCT ID: NCT01602523 Active, not recruiting - Emphysema Clinical Trials

Effect of Symbicort on Sleep Quality in Patients With Emphysema

Start date: March 2011
Phase: Phase 3
Study type: Interventional

This study will look at the effects of the drug Symbicort on sleep quality. Symbicort is an inhaled medication that contains 2 drugs. One is a medication that opens up the airways (formoterol). The other is a steroid to decrease airway inflammation (budesonide). Symbicort is not an experimental medication. It is approved by the Food and Drug Administration for use in patients with emphysema. Patients with severe emphysema commonly sleep poorly. The cause of poor sleep in these patients is unknown. Symbicort may improve sleep quality by opening the airways and reducing lung inflammation. It is not known for sure if these effects actually improve sleep and quality of life. It is hoped that this study will answer this question.